# CD47;Rag2;IL-2rγ triple knock-out mice pre-conditioning with busulfan could be a novel platform for generating hematopoietic stem cells engrafted humanized mice

**Authors:** Kang-Hyun Kim, Sang-wook Lee, In-Jeoung Baek, Hye-Young Song, Seon-Ju Jo, Je-Won Ryu, Seung-Hee Ryu, Jin-Hee Seo, Jong-Choon Kim, Seung-Ho Heo

PMC · DOI: 10.3389/fimmu.2024.1365946 · Frontiers in Immunology · 2024-07-26

## TL;DR

This study introduces a new mouse model that can be used to create humanized mice with improved long-term human immune system development and reduced disease risks.

## Contribution

The novel RTKO mouse strain with CD47, Rag2, and IL-2rγ knockouts and busulfan pre-conditioning is proposed as an improved platform for humanized mice.

## Key findings

- RTKO mice pretreated with busulfan showed the highest and longest maintenance of human CD45+ cells over 40 weeks.
- Human leukocyte reconstruction, including hCD3, was most prominent in RTKO busulfan-treated mice.
- Only two mice died in all groups, with no life-threatening GvHD except in the deceased mice.

## Abstract

Humanized mouse models to recapitulate human biological systems still have limitations, such as the onset of lethal graft-versus-host disease (GvHD), a variable success rate, and the low accessibility of total body irradiation (TBI). Recently, mice modified with the CD47-SIRPA axis have been studied to improve humanized mouse models. However, such trials have been rarely applied in NOD mice. In this study, we created a novel mouse strain, NOD-CD47nullRag2nullIL-2rγnull (RTKO) mice, and applied it to generate humanized mice.

Four-week-old female NOD-Rag2nullIL-2rγnull (RID) and RTKO mice pre-conditioned with TBI or busulfan (BSF) injection were used for generating human CD34+ hematopoietic stem cell (HSC) engrafted humanized mice. Clinical signs were observed twice a week, and body weight was measured once a week. Flow cytometry for human leukocyte antigens was performed at intervals of four weeks or two weeks, and mice were sacrificed at 48 weeks after HSC injection.

For a long period from 16 to 40 weeks post transplantation, the percentage of hCD45 was mostly maintained above 25% in all groups, and it was sustained the longest and highest in the RTKO BSF group. Reconstruction of human leukocytes, including hCD3, was also most prominent in the RTKO BSF group. Only two mice died before 40 weeks post transplantation in all groups, and there were no life-threatening GvHD lesions except in the dead mice. The occurrence of GvHD has been identified as mainly due to human T cells infiltrating tissues and their related cytokines.

Humanized mouse models under all conditions applied in this study are considered suitable models for long-term experiments based on the improvement of human leukocytes reconstruction and the stable animal health. Especially, RTKO mice pretreated with BSF are expected to be a valuable platform not only for generating humanized mice but also for various immune research fields.

## Linked entities

- **Genes:** CD47 (CD47 molecule) [NCBI Gene 961], RAG2 (recombination activating 2) [NCBI Gene 5897], IL2RG (interleukin 2 receptor subunit gamma) [NCBI Gene 3561]
- **Proteins:** SIRPA (signal regulatory protein alpha)
- **Chemicals:** busulfan (PubChem CID 2478)
- **Diseases:** graft-versus-host disease (MONDO:0013730), GvHD (MONDO:0013730)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** CD34 (CD34 molecule) [NCBI Gene 947], Cd47 (CD47 antigen (Rh-related antigen, integrin-associated signal transducer)) [NCBI Gene 16423] {aka 9130415E20Rik, B430305P08Rik, IAP, Itgp}, Sirpa (signal-regulatory protein alpha) [NCBI Gene 19261] {aka Bit, CD172a, Idd13.2, P84, Ptpns1, SHP-1}
- **Diseases:** GvHD (MESH:D006086)
- **Chemicals:** BSF (MESH:D002066)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11310007/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11310007/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC11310007/full.md

---
Source: https://tomesphere.com/paper/PMC11310007